Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Roger Arteaga"'
Autor:
Jayme Fernandes, Igor Estevao, Joaquim Gascon, Isabela Ribeiro, Erika Correia, Rudy Parrado, Graeme Bilbe, Faustino Torrico, Gimena Rojas, Lourdes Ortiz, Daniel Lozano, Wilson Garcia, Uriel Ortega-Rodriguez, Alejandro Palacios, Roger Arteaga, Michel Vaillant, Katsura Hata, Lineth Garcia, Edgar Schuck, Fabiana Barreira, Cristina Alonso-Vega, Makoto Asada, Jimmy Pinto, Juan Carlos Ramirez, Tayná Barboza, Nathalie Strub-Wourgaft, María-Jesús Pinazo, Anabelle de la Barra, Bethania Blum, Maria Tays Mendes, Sergio Sosa-Estani, Alejandro G. Schijman, Igor C. Almeida, Ivana Martinez, Noritsugu Maki, Jhonny Camacho Borja
Publikováno v:
The Lancet. Infectious diseases. 21(8)
Current treatment for Chagas disease with the only available drugs, benznidazole or nifurtimox, has substantial limitations, including long treatment duration and safety and tolerability concerns. We aimed to evaluate the efficacy and safety of new b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd6105a98e4de2ebe2b2c1177ce5d150
https://pubmed.ncbi.nlm.nih.gov/34331889
https://pubmed.ncbi.nlm.nih.gov/34331889
Autor:
Alejandro Marcel Hasslocher-Moreno, Pedro Emmanuel Alvarenga Americano do Brasil, Lucia Maria Brum-Soares, Carina Perotti Fux, Juan-Carlos Cubides, Roberto M. Saraiva, Roger Arteaga Mejía, Marcelo Teixeira de Holanda, Gilberto Marcelo Sperandio da Silva, Luiz Henrique Conde Sangenis, Andréa Silvestre de Sousa, Mauro Felippe Felix Mediano
Publikováno v:
The Journal of antimicrobial chemotherapy. 72(9)
Background Up to half of patients with Chagas' disease under benznidazole treatment present adverse drug reactions (ADRs) and up to one-third do not complete standard treatment. Objectives To verify the incidence and possible factors associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d13f0ae822a209858f218ef600037532
https://pubmed.ncbi.nlm.nih.gov/28645201
https://pubmed.ncbi.nlm.nih.gov/28645201
Autor:
da Silva, Gilberto Marcelo Sperandio, Mediano, Mauro Felippe Felix, Hasslocher-Moreno, Alejandro Marcel, de Holanda, Marcelo Teixeira, de Sousa, Andrea Silvestre, Sangenis, Luiz Henrique Conde, do Brasil, Pedro Emmanuel Alvarenga Americano, Mejía, Roger Arteaga, Fux, Carina Perotti, Cubides, Juan-Carlos, Saraiva, Roberto Magalhães, Brum-Soares, Lucia Maria, Sperandio da Silva, Gilberto Marcelo, Felix Mediano, Mauro Felippe, Holanda, Marcelo Teixeira de, Silvestre de Sousa, Andrea, Brasil, Pedro Emmanuel Alvarenga Americano do, Mediano, M M F, Mediano, M F F
Publikováno v:
Journal of Antimicrobial Chemotherapy (JAC); Sep2017, Vol. 72 Issue 9, p2596-2601, 6p
Autor:
Sperandio da Silva GM; Evandro Chagas National Institute of Infectious Diseases (INI)-Oswaldo Cruz Foundation (Fiocruz), Manguinhos, Rio de Janeiro, Brazil., Mediano MFF; Evandro Chagas National Institute of Infectious Diseases (INI)-Oswaldo Cruz Foundation (Fiocruz), Manguinhos, Rio de Janeiro, Brazil., Hasslocher-Moreno AM; Evandro Chagas National Institute of Infectious Diseases (INI)-Oswaldo Cruz Foundation (Fiocruz), Manguinhos, Rio de Janeiro, Brazil., Holanda MT; Evandro Chagas National Institute of Infectious Diseases (INI)-Oswaldo Cruz Foundation (Fiocruz), Manguinhos, Rio de Janeiro, Brazil., Silvestre de Sousa A; Evandro Chagas National Institute of Infectious Diseases (INI)-Oswaldo Cruz Foundation (Fiocruz), Manguinhos, Rio de Janeiro, Brazil., Sangenis LHC; Evandro Chagas National Institute of Infectious Diseases (INI)-Oswaldo Cruz Foundation (Fiocruz), Manguinhos, Rio de Janeiro, Brazil., Brasil PEAAD; Evandro Chagas National Institute of Infectious Diseases (INI)-Oswaldo Cruz Foundation (Fiocruz), Manguinhos, Rio de Janeiro, Brazil., Mejía RA; Médecins Sans Frontières (MSF), Operational Center Barcelona (OCBA), 08001 Barcelona, Spain., Fux CP; Médecins Sans Frontières (MSF), Operational Center Barcelona (OCBA), 08001 Barcelona, Spain., Cubides JC; Médecins Sans Frontières (MSF), Brazilian Medical Unit (BRAMU), Glória, Rio de Janeiro, Brazil., Saraiva RM; Evandro Chagas National Institute of Infectious Diseases (INI)-Oswaldo Cruz Foundation (Fiocruz), Manguinhos, Rio de Janeiro, Brazil., Brum-Soares LM; Médecins Sans Frontières (MSF), Brazilian Medical Unit (BRAMU), Glória, Rio de Janeiro, Brazil.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2017 Sep 01; Vol. 72 (9), pp. 2596-2601.